The price of lenvatinib (generic name) varies depending on factors such as dosage, region, and medical insurance policies, typically fluctuating between 2,000 and 8,000 yuan per box. The exact price depends on the actual purchasing channel. This is a prescription drug and must be used strictly according to a doctor's prescription.
Price Range
Different Dosages: The common dosage of lenvatinib is 4mg/capsule × 30 capsules/box, priced at approximately 2,000-6,000 yuan; some larger dosages (such as 10mg/capsule) or imported versions may be more expensive, reaching up to 8,000 yuan per box.
Regional Differences: Prices in first-tier cities or large hospitals may be slightly higher than in primary healthcare institutions; different provinces' bidding and procurement prices, transportation costs, etc., will also affect the final selling price.
Medical Insurance Policies
Partially Covered by Medical Insurance: Lenvatinib is included in the national medical insurance catalog, but its indications are strictly limited (such as advanced liver cancer), and the reimbursement rate varies depending on the regional medical insurance policy, typically ranging from 50% to 70%.
Patient Burden: After medical insurance reimbursement, the out-of-pocket cost may be reduced to 1000-3000 RMB per box. A prescription and diagnosis certificate are required.
Purchase Channels
Hospital Pharmacies: Requires a doctor's prescription; some hospitals require advance appointments.
Compliant Pharmacies: Choose qualified and reputable pharmacies to avoid purchasing medications through unofficial channels and the risk of counterfeit or substandard drugs.
Precautions for Use
Strictly Follow Doctor's Orders: Lenvatinib is used to treat malignant tumors such as thyroid cancer and liver cancer. The dosage needs to be adjusted according to the patient's condition; do not increase, decrease, or discontinue the medication on your own.
Side Effect Management: Common adverse reactions include hypertension and proteinuria. Liver and kidney function, blood pressure, and other indicators need to be monitored regularly during medication.
Special Populations: Contraindicated in pregnant women, breastfeeding women, and patients with liver dysfunction; inform your doctor in advance if using this medication in combination with other drugs.
If you need to use this medication, it is recommended to consult an oncologist or hepatobiliary surgeon for an assessment of your condition and to obtain a prescription. Consider the medical insurance policy when choosing a more cost-effective treatment plan.
